Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medicus Sciences Acquisition has a Cash Ratio of 17.76. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Medicus Sciences Acquisition's Cash Ratio or its related term are showing as below:
MSACW'
s Cash Ratio Range Over the Past 10 Years
Min: 9.98 Med: 17.76 Max: 50.71
Current: 17.76
During the past 2 years, Medicus Sciences Acquisition's highest Cash Ratio was 50.71. The lowest was 9.98. And the median was 17.76.
Medicus Sciences Acquisition (NAS:MSACW) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Medicus Sciences Acquisition Cash Ratio Related Terms
Medicus Sciences Acquisition Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Shell Companies subindustry, Medicus Sciences Acquisition's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicus Sciences Acquisition Cash Ratio vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Medicus Sciences Acquisition's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Medicus Sciences Acquisition's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicus Sciences Acquisition (MSACW) has a Cash Ratio of 17.76 as of Sep. 2022. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Medicus Sciences Acquisition and its competitors. This is near median its historical median of 17.76. Over the past decade, Medicus Sciences Acquisition's Cash Ratio has ranged from 9.98 to 50.71.
Is Medicus Sciences Acquisition's Cash Ratio too high?
Medicus Sciences Acquisition's current Cash Ratio of 17.76 is near median its 10-year median of 17.76. Over the past 10 years, this metric has ranged from a low of 9.98 to a high of 50.71. The Diversified Financial Services industry median Cash Ratio is 2.12. Medicus Sciences Acquisition's value of 17.76 is 739.7% above this industry median. Overall, Medicus Sciences Acquisition has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Medicus Sciences Acquisition's Cash Ratio compare to GENQ and DUET?
Medicus Sciences Acquisition's Cash Ratio of 17.76 can be compared against companies in the Diversified Financial Services industry. The industry median Cash Ratio is 2.12. Medicus Sciences Acquisition's value of 17.76 is 739.7% above this benchmark. Historically, Medicus Sciences Acquisition's own Cash Ratio has ranged from 9.98 to 50.71 over the past decade. While the company's 10-year median is 17.76 vs. the industry median of 2.12, Medicus Sciences Acquisition has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Diversified Financial Services company?
The median Cash Ratio among Diversified Financial Services companies is 2.12, based on 422 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicus Sciences Acquisition's current Cash Ratio of 17.76 is 739.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Medicus Sciences Acquisition and its competitors. For the Diversified Financial Services industry, the median Cash Ratio is 2.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicus Sciences Acquisition's current Cash Ratio is 17.76, which is near median its own 10-year median of 17.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicus Sciences Acquisition stock overvalued right now?
Medicus Sciences Acquisition (MSACW) has a current Cash Ratio of 17.76. The current Cash Ratio is 17.76, which is near median its 10-year median of 17.76 and 739.7% above the Diversified Financial Services industry median of 2.12. Medicus Sciences Acquisition's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Medicus Sciences Acquisition (MSACW), the current Cash Ratio is 17.76 as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MSACW has been successfully added to your 
